GTRI is building a world-leading gene therapy company addressing a broad range of CNS and monogenic disorders.

Gene therapies are currently being introduced into clinical practice and I am sure that they have promising medical and economic benefits. I have seen many patients who suffer from serious neurodegenerative diseases. Even as I speak, a number of patients are awaiting radical gene therapy treatment. Accordingly, I would like to implement the therapy in a practical clinical setting as soon as possible. By making the technology available, I shall improve their QOL and prolong their comfort and happiness. Gene therapy is effective means for achieving these goals and I would strongly like to put it into practice immediately, or in the near future, if possible.